NATR

Jonathan David Lanoy

Known title: SVP, Finance - Interim CFOCIK: 0001945776

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

Nature's Sunshine Q2 Earnings Reviewed Against Peers. A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.

this person other insiders at NATR

Transaction History

NATR▲ Buy$0
NATR▲ Buy$0
NATR▼ Sell$3K
NATR▲ Buy$0
NATR▼ Sell$12K
NATR▲ Buy$0
NATR▼ Sell$8K
NATR▼ Sell$26K
NATR▼ Sell$99K
NATR▼ Sell$21K
NATR▼ Sell$25K
NATR▼ Sell$8K
NATR▲ Buy$0
NATR▲ Buy$136K
NATR▼ Sell—
NATR▼ Sell$102K
NATR▲ Buy$0
NATR▼ Sell$1K
NATR▲ Buy$0
NATR▼ Sell$7K
NATR▼ Sell$83K
NATR▼ Sell$5K
NATR▼ Sell$12K
NATR▲ Buy$131K
NATR▼ Sell$35K
NATR▼ Sell$5K
NATR▼ Sell$21K
NATR▼ Sell$4K
NATR▲ Buy$0
NATR▼ Sell$39K
NATR▼ Sell$4K
NATR▲ Buy$0
NATR▼ Sell$1K
NATR▼ Sell$2K
NATR▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.